BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6304328)

  • 1. Increased cyclic GMP content in confluent and serum-restricted heart cell cultures exposed to polyamines.
    Clô C; Tantini B; Pignatti C; Caldarera CM
    J Mol Cell Cardiol; 1983 Feb; 15(2):139-43. PubMed ID: 6304328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of an effect of the lithium-induced increase in cyclic GMP on the cyclic GMP-stimulated phosphodiesterase (PDE II). Evidence for cyclic AMP-specific hydrolysis.
    Harvey B; Carstens M; Taljaard J
    Neurochem Res; 1993 Oct; 18(10):1095-100. PubMed ID: 8255358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
    Tang KM; Jang EK; Haslam RJ
    Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of polyamine-induced decrease of cyclic AMP content by cyclic AMP-phosphodiesterase in chick heart cell cultures.
    Clô C; Tantini B; Coccolini MN; Caldarera CM
    J Mol Cell Cardiol; 1981 Aug; 13(8):773-6. PubMed ID: 6267306
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
    Lochner A; Genade S; Tromp E; Opie L; Moolman J; Thomas S; Podzuweit T
    Mol Cell Biochem; 1998 Sep; 186(1-2):169-75. PubMed ID: 9774198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells.
    Laasberg T; Pihlak A; Neuman T; Paves H; Saarma M
    FEBS Lett; 1988 Nov; 239(2):367-70. PubMed ID: 2460374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamines and cellular adenosine 3' :5'-cyclic monophosphate.
    Clô C; Caldarera CM; Tantini B; Benalal D; Bachrach U
    Biochem J; 1979 Sep; 182(3):641-9. PubMed ID: 229823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
    Whalin ME; Scammell JG; Strada SJ; Thompson WJ
    Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases in cultured normal and RCS rat pigment epithelium: kinetics of cyclic AMP and cyclic GMP hydrolysis.
    Kurtz MJ; Edwards RB; Schmidt SY
    Exp Eye Res; 1987 Jul; 45(1):67-75. PubMed ID: 2820772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hepatocyte growth factor on cyclic nucleotide-dependent signaling and steroidogenesis in rat ovarian granulosa cells in vitro.
    Zachow RJ; Woolery JK
    Biol Reprod; 2002 Aug; 67(2):454-9. PubMed ID: 12135881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons.
    Moon C; Simpson PJ; Tu Y; Cho H; Ronnett GV
    J Neurochem; 2005 Oct; 95(1):200-9. PubMed ID: 16181424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.